AstraZeneca plc (NYSE: AZN) announced it has started manufacturing experimental coronavirus vaccines developed by Oxford University and the company is reportedly in talks with Gilead about a merger
Source: AstraZeneca (AZN): Gilead Sciences (GILD) Merger Talks, Oxford University Vaccine Plans, Bill And Melinda Gates Foundation Partnership
Some of the posts we share are controversial and we do not necessarily agree with them in the whole extend. Sometimes we agree with the content or part of it but we do not agree with the narration or language. Nevertheless we find them somehow interesting, valuable and/or informative or we share them, because we strongly believe in freedom of speech, free press and journalism. We strongly encourage you to have a critical approach to all the content, do your own research and analysis to build your own opinion.
We would be glad to have your feedback.